Comprehensive evaluation of deep and graph learning on drug–drug interactions prediction
Briefings in Bioinformatics · 2023
DOI: 10.1093/bib/bbad235 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, 2023. Verfasst von Xuan Lin und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Computer Science, Xiangtan University, Xiangtan, China. Hauptthemen laut MEDLINE: Artificial Intelligence, Neural Networks, Computer. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 140 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Researchand Development Program of China, Science and Technology Innovation Program of Hunan Province of China.
Abstract (Originalsprache)
Recent advances and achievements of artificial intelligence (AI) as well as deep and graph learning models have established their usefulness in biomedical applications, especially in drug–drug interactions (DDIs). DDIs refer to a change in the effect of one drug to the presence of another drug in the human body, which plays an essential role in drug discovery and clinical research. DDIs prediction through traditional clinical trials and experiments is an expensive and time-consuming process. To correctly apply the advanced AI and deep learning, the developer and user meet various challenges such as the availability and encoding of data resources, and the design of computational methods. This review summarizes chemical structure based, network based, natural language processing based and hybrid methods, providing an updated and accessible guide to the broad researchers and development community with different domain knowledge. We introduce widely used molecular representation and describe the theoretical frameworks of graph neural network models for representing molecular structures. We present the advantages and disadvantages of deep and graph learning methods by performing comparative experiments. We discuss the potential technical challenges and highlight future directions of deep and graph learning models for accelerating DDIs prediction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Computer Science, Xiangtan University, Xiangtan, China.
- Key Laboratory of Intelligent Computing and Information Processing of Ministry of Education, Xiangtan University, Xiangtan, China.
- College of Informatics, Huazhong Agricultural University, China.
- Northwestern Polytechnical University, Xian, China.
- Xiangya School of Pharmaceutical Sciences, Central South University, China.
- AIDD department of Yuyao Biotech, Shanghai, China.
Förderung
- National Natural Science Foundation of China
- National Key Researchand Development Program of China
- Science and Technology Innovation Program of Hunan Province of China
- High-Level Talent Aggregation Project in Hunan Province, China Innovation Team
- Hunan Provincial Natural Science Foundation of China
- Science and Technology Innovation 2030-Major Project
- General Project of Hunan Provincial Education Department
- Open Research Projects of Zhejiang Lab
Zitieren
APA
Lin, X., Dai, L., Zhou, Y., Yu, Z. G., Zhang, W., Shi, J. Y., Cao, D. S., Zeng, L., Chen, H., Song, B., Yu, P. S., & Zeng, X. (2023). Comprehensive evaluation of deep and graph learning on drug–drug interactions prediction. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbad235
Vancouver
Lin X, Dai L, Zhou Y, Yu ZG, Zhang W, Shi JY, et al. Comprehensive evaluation of deep and graph learning on drug–drug interactions prediction. Briefings in Bioinformatics. 2023. doi:10.1093/bib/bbad235
BibTeX
@article{Lin2023,
author = {Lin, Xuan and Dai, Lichang and Zhou, Yafang and Yu, Zu-Guo and Zhang, Wen and Shi, Jian-Yu and Cao, Dong-Sheng and Zeng, Li and Chen, Haowen and Song, Bosheng and Yu, Philip S and Zeng, Xiangxiang},
title = {Comprehensive evaluation of deep and graph learning on drug–drug interactions prediction},
journal = {Briefings in Bioinformatics},
year = {2023},
doi = {10.1093/bib/bbad235}
}
EUVIMED